Omnicell to Release Second Quarter 2021 Financial Results on July 29, 2021

Rhea-AI Summary

Omnicell, Inc. (Nasdaq: OMCL) is set to release its financial results for Q2 2021 before the market opens on July 29, 2021. A conference call to discuss these results will follow at 8:30 a.m. ET. The company's solutions aim to enhance medication management across healthcare systems, utilized by over 7,000 facilities globally. Omnicell focuses on improving patient outcomes and reducing costs through automation and analytics, benefiting over 50,000 pharmacies in North America and the UK. Investors can access the call via phone or the company’s investor relations website.

Positive

• Anticipating financial results release for Q2 2021, indicating company transparency.
• More than 7,000 global facilities utilize Omnicell's solutions, showcasing broad market adoption.

Negative

• None.

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter of 2021 before the open of the market on Thursday, July 29, 2021. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.

All interested parties are invited to listen to the live call and presentation by dialing (855) 451-1210 in the U.S. or (236) 714-3867 in international locations. The Conference ID is 6356636. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the Autonomous Pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings.

Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

To learn more, visit www.omnicell.com. From time to time, Omnicell may use the Company's investor relations site and other online social media channels, including its Twitter handle www.twitter.com/omnicell, LinkedIn page www.linkedin.com/company/omnicell, and Facebook page www.facebook.com/omnicellinc, to disclose material non-public information and comply with its disclosure obligations under Regulation Fair Disclosure ("FD").

Omnicell and the Omnicell logo are registered trademarks of Omnicell, Inc. in the United States and other countries.

OMCL-E

View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005199/en/

FAQ

When will Omnicell release its Q2 2021 financial results?

Omnicell will release its Q2 2021 financial results on July 29, 2021, before the market opens.

What time is the Omnicell conference call for Q2 2021 results?

The conference call for Omnicell's Q2 2021 results is scheduled for 8:30 a.m. ET on July 29, 2021.

How can I listen to the Omnicell Q2 2021 results call?

You can listen to the Omnicell Q2 2021 results call by dialing (855) 451-1210 for the U.S. or (236) 714-3867 internationally.

What is the significance of Omnicell's medication management solutions?

Omnicell's medication management solutions are designed to enhance operational efficiency, reduce medication errors, and improve patient safety.

Where can I find more information about Omnicell?

For more information about Omnicell, visit their investor relations page at www.omnicell.com.